Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2019-03-08 | Robert T. Allen, Director since December 2018. Serves on Audit Committee and Compensation Committee. 2018 Director compensation total $1,834. |
| 2020-03-06 | Mr. Allen is a certified public accountant and seasoned executive with 38 years of operating and financial experience focused on the healthcare services sector. He is currently a principal at RLA Advisors, which provides advisory services to leadership teams in rapidly expanding organizations and turnaround situations. Mr. Allen most recently served as President of Coram/CVS Infusion Services, from 2013 to 2014. Prior to serving as President, he held positions of COO and CFO at Coram between 2006 and 2013. Prior to Coram, Mr. Allen held leadership roles at Titan Health Corporation and American Medical Response. Mr. Allen also currently sits on the board of Oceans Healthcare, an operator of hospitals in the Southeast. The Audit Committee is currently comprised of Messrs. Anderson (chair), Allen and Fletcher and Ms. Frommer. The Nomination and Governance Committee currently consists of Messrs. Manko (chair), Allen and Fletcher. The 2019 fiscal year director compensation table shows Robert T. Allen with total compensation of $50,000. |
| 2021-04-05 | Mr. Allen is a certified public accountant and seasoned executive with 38 years of operating and financial experience focused on the healthcare services sector. He is currently a principal at RLA Advisors, which provides advisory services to leadership teams in rapidly expanding organizations and turnaround situations. Mr. Allen most recently served as President of Coram/CVS Infusion Services, from 2013 to 2014. Prior to serving as President, he held positions of COO and CFO at Coram between 2006 and 2013. Prior to Coram, Mr. Allen held leadership roles at Titan Health Corporation and American Medical Response. Mr. Allen also currently sits on the board of Oceans Healthcare, an operator of hospitals in the Southeast. The Audit Committee is currently comprised of Messrs. Anderson (chair), Allen and Fletcher and Ms. Frommer. Each member of this committee is “independent” within the meaning of applicable SEC rules and standards of the Nasdaq Stock Market LLC (the “Nasdaq”). The Board of Directors has designated Mr. Anderson as the audit committee financial expert, as currently defined under the SEC rules. The Nominating and Governance Committee currently consists of Messrs. Manko (chair), Allen and Fletcher. Each member of this committee is “independent” within the meaning of applicable SEC rules and the standards of the Nasdaq. The Compensation Committee currently consists of Messrs. Allen (chair), Manko and Frommer. Each member of this committee is “independent” within the meaning of applicable SEC rules and the standards of the Nasdaq. The Audit Committee held six meetings including two special meetings in connection with meetings of the full Board during the fiscal year ended December 31, 2020. The Nominating and Governance Committee held five meetings including one special meeting during the fiscal year ended December 31, 2020. The Compensation Committee held fifteen meetings during the fiscal year ended December 31, 2020. 2020 FISCAL YEAR DIRECTOR COMPENSATION TABLE: Robert T. Allen Fees Earned or Paid in Cash ($) 25,000 Stock Awards ($) 25,000 All Other Compensation ($) — Total ($) 50,000. |
Data sourced from SEC filings. Last updated: 2025-08-30